Leavell Investment Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,899
| Closed | -$288K | – | 395 |
|
|
2020
Q4 | $288K | Sell |
1,899
-23
| -1% | -$3.49K | 0.02% | 336 |
|
|
2020
Q3 | $260K | Buy |
1,922
+23
| +1% | +$3.11K | 0.02% | 332 |
|
|
2020
Q2 | $260K | Hold |
1,899
| – | – | 0.03% | 326 |
|
|
2020
Q1 | $205K | Buy |
1,899
+99
| +6% | +$10.7K | 0.02% | 341 |
|
|
2019
Q4 | $217K | Buy |
+1,800
| New | +$217K | 0.02% | 370 |
|
|
2019
Q3 | – | Sell |
-1,920
| Closed | -$209K | – | 386 |
|
|
2019
Q2 | $209K | Hold |
1,920
| – | – | 0.02% | 372 |
|
|
2019
Q1 | $215K | Buy |
+1,920
| New | +$215K | 0.02% | 358 |
|
|
2018
Q4 | – | Sell |
-1,920
| Closed | -$234K | – | 361 |
|
|
2018
Q3 | $234K | Hold |
1,920
| – | – | 0.03% | 350 |
|
|
2018
Q2 | $211K | Hold |
1,920
| – | – | 0.02% | 361 |
|
|
2018
Q1 | $205K | Hold |
1,920
| – | – | 0.02% | 363 |
|
|
2017
Q4 | $205K | Hold |
1,920
| – | – | 0.02% | 366 |
|
|
2017
Q3 | $214K | Buy |
+1,920
| New | +$214K | 0.03% | 354 |
|
|
2016
Q2 | – | Sell |
-3,270
| Closed | -$284K | – | 387 |
|
|
2016
Q1 | $284K | Sell |
3,270
-25,575
| -89% | -$2.22M | 0.04% | 310 |
|
|
2015
Q4 | $3.25M | Sell |
28,845
-900
| -3% | -$101K | 0.48% | 54 |
|
|
2015
Q3 | $3.01M | Buy |
29,745
+150
| +0.5% | +$15.2K | 0.48% | 56 |
|
|
2015
Q2 | $3.64M | Buy |
29,595
+150
| +0.5% | +$18.4K | 0.57% | 44 |
|
|
2015
Q1 | $3.37M | Buy |
29,445
+1,200
| +4% | +$137K | 0.51% | 52 |
|
|
2014
Q4 | $2.86M | Buy |
28,245
+11,820
| +72% | +$1.2M | 0.44% | 65 |
|
|
2014
Q3 | $1.5M | Buy |
16,425
+5,625
| +52% | +$513K | 0.24% | 121 |
|
|
2014
Q2 | $925K | Sell |
10,800
-3,000
| -22% | -$257K | 0.15% | 175 |
|
|
2014
Q1 | $1.09M | Buy |
13,800
+600
| +5% | +$47.3K | 0.18% | 152 |
|
|
2013
Q4 | $999K | Buy |
13,200
+600
| +5% | +$45.4K | 0.17% | 160 |
|
|
2013
Q3 | $880K | Buy |
12,600
+3,300
| +35% | +$230K | 0.16% | 155 |
|
|
2013
Q2 | $539K | Buy |
+9,300
| New | +$539K | 0.1% | 199 |
|